Allopurinol, uric acid, and oxidative stress in cardiorenal disease (Q37872639)

24 August 2017

1 reference

title

Allopurinol, uric acid, and oxidative stress in cardiorenal disease (English)

1 reference

24 August 2017

1 reference

2

Adrian Covic

1 reference

24 August 2017

Markus Riegersperger

1

1 reference

PubMed ID

21547469

24 August 2017

David Goldsmith

series ordinal

3

1 reference

24 August 2017

10 March 2011

1 reference

International Urology and Nephrology

24 August 2017

1 reference

24 August 2017

43

1 reference

24 August 2017

441-449

1 reference

24 August 2017

2

1 reference

Menopause, postmenopausal hormone use and serum uric acid levels in US women--the Third National Health and Nutrition Examination Survey

24 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effects of angiotensin II receptor blockers on renal handling of uric acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

J-shaped mortality relationship for uric acid in CKD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Allopurinol metabolism in a patient with xanthine oxidase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: results of a phase II randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Resolution of gouty tophi after twelve weeks of pegloticase treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Treating gout with pegloticase, a PEGylated urate oxidase, provides insight into the importance of uric acid as an antioxidant in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of fenofibrate on uric acid metabolism and urate transporter 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Concentration-dependent inhibitory effect of irbesartan on renal uric acid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Sevelamer decreases serum uric acid concentration through adsorption of uric acid in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Use of sevelamer hydrochloride as an oxalate binder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Prevalence and risk factors associated with chronic kidney disease in adults over 40 years: a population study from Central China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Clustering of cardiovascular risk factors and blood pressure control status in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Association between serum uric acid and development of type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Hyperuricemia and incident heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Gout, allopurinol use, and heart failure outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid and left ventricular hypertrophy in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Higher serum uric acid on admission is associated with higher short-term mortality and poorer long-term survival after myocardial infarction: retrospective prognostic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Elevated uric acid increases the risk for kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

The independent association between serum uric acid and graft outcomes after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid and the development of metabolic syndrome in women and men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Association of uric acid with risk factors for chronic kidney disease and metabolic syndrome in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

The association between serum urate levels and arterial stiffness/endothelial function in stroke survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of uric acid on coronary microvascular endothelial function in women: association with eGFR and ADMA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Inactivation of nitric oxide by uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Single exposure gamma-irradiation amplifies xanthine oxidase activity and induces endothelial dysfunction in rat aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Allopurinol reduces B-type natriuretic peptide concentrations and haemoglobin but does not alter exercise capacity in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Association between allopurinol and mortality in heart failure patients: a long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Inhibition of xanthine oxidase improves myocardial contractility in patients with ischemic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Oxypurinol improves coronary and peripheral endothelial function in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Hyperuricemia induces endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Hyperuricemia exacerbates chronic cyclosporine nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Immune suppression blocks sodium-sensitive hypertension following recovery from ischemic acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Recovery from renal ischemia-reperfusion injury is associated with altered renal hemodynamics, blunted pressure natriuresis, and sodium-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Clinical value of serum uric Acid in patients with suspected coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Relationship between serum uric Acid levels, metabolic syndrome, and arterial stiffness in korean

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Association of nephrolithiasis and gene for glucose transporter type 9 (SLC2A9): study of 145 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Relationship between plasma oxipurinol concentrations and xanthine oxidase activity in volunteers dosed with allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Severe allopurinol toxicity. Description and guidelines for prevention in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Angiotensin II induces vascular smooth muscle cell replication independent of blood pressure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric acid in hypertension and renal disease: the chicken or the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Uric Acid Levels Are Associated With All-Cause and Cardiovascular Disease Mortality Independent of Systemic Inflammation in Men From the General Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11255-011-9929-6

Letter by Kielstein et al regarding article, "High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid"

21 January 2018

1 reference

12 December 2020

Effects of purine derivatives on calcitriol metabolism in rats

1 reference

12 December 2020

Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease

1 reference

12 December 2020

The effect of acute guaifenesin administration on serum uric acid.

1 reference

12 December 2020

A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients

1 reference

12 December 2020

Role of uric acid in the link between arterial stiffness and cardiac hypertrophy: a cross-sectional study

1 reference

12 December 2020

Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients

1 reference

12 December 2020

Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?

1 reference

12 December 2020

Elevated serum uric acid is an independent predictor for cardiovascular events in patients with severe coronary artery stenosis: subanalysis of the Japanese Coronary Artery Disease (JCAD) Study

1 reference

12 December 2020

A preliminary investigation of the association between serum uric acid and impaired renal function.

1 reference

12 December 2020

Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study

1 reference

12 December 2020

Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C

1 reference

12 December 2020

Uric acid, cardiovascular mortality, and long-term outcomes in CKD

1 reference

12 December 2020

The distribution of arteriolosclerosis along the arterioles in DOCA hypertensive rats

1 reference

12 December 2020

Association between endothelial dysfunction and hyperuricaemia.

1 reference

12 December 2020

Uric acid elevation in atrial fibrillation

1 reference

12 December 2020

NADH oxidase activity of human xanthine oxidoreductase--generation of superoxide anion

1 reference

12 December 2020

Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin

1 reference

12 December 2020

Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions

1 reference

12 December 2020

Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat

1 reference

12 December 2020

The effects of lowering uric acid levels using allopurinol on markers of metabolic syndrome in end-stage renal disease patients: a pilot study.

1 reference

12 December 2020

Uric Acid is not an independent predictor of cardiovascular death in patients with angiographically proven coronary artery disease.

1 reference

12 December 2020

Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia

1 reference

12 December 2020

Effect of uric acid on plasma levels of 1,25(OH)2D in renal failure.

1 reference

12 December 2020

The ALLHAT and the cardioprotection conferred by diuretics in hypertensive patients: a connection with uric acid?

1 reference

12 December 2020

10.1007/S11255-011-9929-6

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21547469